Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats
- 24 January 2014
- journal article
- research article
- Published by Elsevier BV in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 24 (4), 408-415
- https://doi.org/10.1016/j.numecd.2013.09.008
Abstract
No abstract availableKeywords
Funding Information
- “Progetto AGER” (2011-0283)
- National Institute for Cardiovascular Research
This publication has 33 references indexed in Scilit:
- Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic RatsPLOS ONE, 2012
- What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of ResveratrolPLOS ONE, 2011
- Resveratrol Potentiates Glucose-stimulated Insulin Secretion in INS-1E β-Cells and Human Islets through a SIRT1-dependent MechanismOnline Journal of Public Health Informatics, 2011
- Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imagingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2American Journal of Physiology-Heart and Circulatory Physiology, 2010
- Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLCJournal of Pharmaceutical and Biomedical Analysis, 2010
- Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1Experimental & Molecular Medicine, 2009
- Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenaseFree Radical Biology & Medicine, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006